OPTIMIZED IOL FOR Astigmatism
- IOL Monofocal, Clear, Toric

- High quality hydrophilic material

IOL SYNTHESIS TORIC

 THE LATEST ALL-IN-ONE INNOVATIONS PLATFORM

ASTIGMATISM PATIENT CARE

  • Astigmatism needs to be treated to reduce the dependency on glasses for distance vision.(1)
  • 78% of the cataract patient population present with corneal astigmatism ≥ 0,5 D.(2)

 

 

NEXT GENERATION ONLINE CALCULATOR

 Takes into account posterior corneal astigmatism.
– Ignoring posterior corneal astigmatism may lead to the incorrect estimation of the total corneal astigmatism.

CLINICAL RESULTS ON ROTATIONAL STABILITY

 

Primary objective: Synthesis 11 mm platform rotational stability analysis with 4 months follow-up.(9)
Prospective monocentric clinical study.
Clinically proven rotational stability:
93% of patients with less than 5° rotation from surgery day (D0)
over a 4 month follow-up period.
Average rotation of 2.93° at 4 months

 

SAFETY

Material
– Acrylic copolymer successfully used for more than 17 years in ophthalmology
– Ultraviolet absorption


Design
– 4 point fixation haptics
– 3 overall diameters to fit the capsular bag:

  • 11 mm from -10.0 D to +15.0 D
  • 10.7 mm from +15.5 D to 22.0 D
  • 10.5 mm from +22.5 D to +40.0 D

– Enhanced C-Edge+ ≤ 5microns 360° square edge

 

 REPRODUCIBILITY

OPTIC

 

      • 6 mm optic across the power range

      • Orientation notch at the optic edge

      • Posterior shift: vaulted design for excellent capsular bag adhesion

      • Aberration neutral

        Aspheric profile

      • Homogeneous surface across the power range for consistent injection forces regardless of IOL diopter.

 

 

OPTICAL QUALITY

MTF (MODULATION TRANSFER FUNCTION)

 Synthesis exceeds ISO 11979-2 standard requirement for optical properties and test methods (0.43 at 100 cycle/mm) at all light conditions and pupil diameter.